Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1884 clinical trials
A Study of HMPL-295S1 in Patients With Advanced Malignant Solid Tumors

The objective of this study is to evaluate the safety, tolerability and PK profile of HMPL-295S1 and determine MTD and/or RP2D in patients with advanced malignant solid tumor. It will be

  • 0 views
  • 11 Sep, 2021
  • 1 location
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors

NECVAX-NEO1 in addition to anti-PD-1 or anti-PD-L1 monoclonal antibody checkpoint inhibitor monotherapy in n=6 patients with solid tumors

  • 0 views
  • 25 May, 2022
  • 1 location
Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

treatment of solid tumors through targeting myeloid derived suppressor cells (MDSCs).

  • 0 views
  • 05 Jun, 2022
  • 3 locations
An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

, pharmacokinetics and pharmacodynamics of BC006 in giant cell tumor of tendon sheath (GCTTS) and other advanced solid tumors.

  • 0 views
  • 23 Mar, 2022
  • 1 location
REGN7075 in Combination With Cemiplimab in Adult Participants With Advanced Solid Tumors (COMBINE-EGFR-1)

patients with advanced solid tumors Dose Expansion: • To assess the preliminary efficacy of REGN7075 in combination with cemiplimab within selected advanced solid tumor-specific cohorts, as

  • 7 views
  • 04 Oct, 2022
  • 8 locations
  • 0 views
  • 04 Oct, 2022
  • 1 location
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

This is a first in human study in patients with advanced or metastatic solid tumors known to have an MTAP deletion. The first part of the study is an open-label, dose escalation and the second

  • 0 views
  • 04 Oct, 2022
  • 6 locations
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors

This study is designed to determine if treatment with HRS-1167 alone is safe, tolerable, and has anti-cancer activity in patients with advanced solid tumors.

  • 0 views
  • 07 Oct, 2022
  • 1 location
A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer

The purpose of this study is to see if TAS0612 is safe in participants with advanced or metastatic solid tumor cancer.

  • 8 views
  • 10 Dec, 2021
  • 3 locations
A Study of ERAS-007 in Patients With Advanced or Metastatic Solid Tumors

dose and schedule of ERAS-007 monotherapy. To evaluate antitumor activity of ERAS-007 in various solid tumors.

  • 0 views
  • 17 Jul, 2021
  • 6 locations